Clinical Trial Update: Xerecept Intravenous Dose Escalation in Japanese and Caucasian Volunteers [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation trial of Xerecept given intravenously in Japanese and Caucasian volunteers to evaluate safety and dosing in edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Edema

Drugs mentioned

• XERECEPT (human corticotropin-releasing factor)

Snippet

Sponsor: Celtic Pharma Development Services | Conditions: Edema | Phase 1 | Status: COMPLETED